The Mexico Medical Cannabis Market size is expected to reach USD 249.6 million by 2025, exhibiting a CAGR 27.7% over the forecast period. Rising adoption of medicinal marijuana for the treatment of chronic conditions such as Alzheimer’s disease, cancer, arthritis, anxiety, and epilepsy is one of the key factors propelling the Mexican medical cannabis market. Furthermore, approval of CBD derivatives for medicinal use is also expected to drive demand in the coming years.
The cannabis industry is booming due to its increasing adoption for medicinal application and imminent legalization for recreational use. In Mexico, marijuana is only legalized for medicinal use and is anticipated to be legalized for recreational purposes in an effort to abolish illicit drug trade and generate tax revenue.
Competition among existing players is moderately high as very few companies have the technology, financial resources, and legal clearance to venture into large-scale manufacturing of marijuana. Medical marijuana has been legalized in Mexico since June 2017. Health licenses for cultivation, harvesting, and production of marijuana in the country are exclusively limited to medicinal and research purposes. Laws pertaining to marijuana are not that well-regulated in the nation and go through a secondary regulation by Federal Commission for the Protection against Health Risks.
Access Sample Report of this report @ https://www.radiantinsights.com/research/mexico-medical-cannabis-market/request-sample
Further key findings from the report suggest:
• In 2018, buds held the largest revenue share accounting for 47.4% owing to easy availability and low price as compared to cannabis extracts
• Cannabis oil is anticipated to emerge as the fastest growing segment, expanding at a CAGR of 33.1% between 2019 and 2025
• Chronic pain held the largest revenue share based on application, owing to rapid adoption of marijuana for the treatment of chronic pain as an alternative to opioids and synthetic drugs
• Key players in this space include Aurora Cannabis; GW Pharmaceuticals plc.; Canopy Growth Corporation; HempMeds; CV Sciences Inc.; Endoca; Isodiol International Inc.; CBD Life; Pharmacielo; CBD American Shaman; and Elixinol.
Access Full Report With TOC @ https://www.radiantinsights.com/research/mexico-medical-cannabis-market
Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Mexico Medical Cannabis Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Mexico Medical Cannabis Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing adoption of medical cannabis for treatment of chronic diseases
3.2.1.2 Impending legalization of cannabis for recreational use
3.2.2 Market Restraint Analysis
3.2.2.1 Lower market access of cannabis due to absence of legalization programs leading to illegal smugglings
3.3 Penetration & Growth Prospects Mapping
3.4 Global Legal Cannabis Trade Route
3.5 Global Legal Cannabis Demand and Supply Analysis
3.6 Mexico Medical Cannabis Market Analysis Tools
3.6.1 Mexico Medical Cannabis Market – PESTLE Analysis
3.6.1.1 Political & Legal Landscape
3.6.1.2 Environmental Landscape
3.6.1.3 Social Landscape
3.6.1.4 Technology Landscape
3.6.2 Industry Analysis – Porter’s
3.6.2.1 Supplier Power: Moderate
3.6.2.2 Buyer Power: Low
3.6.2.3 Substitution Threat: Low
3.6.2.4 Threat from New Entrants: Moderate
3.6.2.5 Competitive Rivalry: Moderately High
3.6.3 Regulatory Scenario
3.6.4 Mexico Cannabis Business Trends
3.6.5 Opportunity Analysis
3.6.6 Patient Pool Analysis (Estimates & Trends)
Browse reports of similar category available with Radiant Insights, Inc.:
- Donor Egg IVF Treatment Market –
- Cardiac Echocardiography Market –
About Radiant Insight
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: Send Email
Phone: (415) 349-0054, Toll Free: 1-888-928-9744
Address:201 Spear Street 1100, Suite 3036
City: San Francisco
State: CA
Country: United States
Website: www.radiantinsights.com/research/mexico-medical-cannabis-market